Prevention and management of non-steroidal anti-inflammatory drugs-induced small intestinal injury
- PMID: 22180706
- PMCID: PMC3237301
- DOI: 10.3748/wjg.v17.i42.4647
Prevention and management of non-steroidal anti-inflammatory drugs-induced small intestinal injury
Abstract
Non-steroidal anti-inflammatory drug (NSAID)-induced small bowel injury is a topic that deserves attention since the advent of capsule endoscopy and balloon enteroscopy. NSAID enteropathy is common and is mostly asymptomatic. However, massive bleeding, stricture, or perforation may occur. The pathogenesis of small intestine injury by NSAIDs is complex and different from that of the upper gastrointestinal tract. No drug has yet been developed that can completely prevent or treat NSAID enteropathy. Therefore, a long-term randomized study in chronic NSAID users is needed.
Keywords: Non-steroidal anti-inflammatory drugs; Prevention; Small intestinal injury; Treatment.
References
-
- Davies NM. Review article: non-steroidal anti-inflammatory drug-induced gastrointestinal permeability. Aliment Pharmacol Ther. 1998;12:303–320. - PubMed
-
- Allison MC, Howatson AG, Torrance CJ, Lee FD, Russell RI. Gastrointestinal damage associated with the use of nonsteroidal antiinflammatory drugs. N Engl J Med. 1992;327:749–754. - PubMed
-
- Fortun PJ, Hawkey CJ. Nonsteroidal antiinflammatory drugs and the small intestine. Curr Opin Gastroenterol. 2007;23:134–141. - PubMed
-
- Lanza FL, Chan FK, Quigley EM. Guidelines for prevention of NSAID-related ulcer complications. Am J Gastroenterol. 2009;104:728–738. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
